Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

LLM 2021 | Inherited and acquired thrombocytopathies

Michele Lambert • 11 Oct 2021
LLM 2021
General

Michele Lambert, MD, The Children’s Hospital of Philadelphia, Philadelphia, PA, provides a brief overview of the causes and treating inherited and acquired thrombocytopathies. Dr Lambert additionally emphasizes how selective serotonin reuptake inhibitors (SSRIs) and non-steroidal anti-inflammatory drugs (NSAIDs) can increase platelet dysfunction and bleeding disorders. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.

Disclosures

Advisory board member for Octapharma, Dova, Principia, Argenx and Shionogi
Consultant for Novartis, Shionogi, Dova, Principia, Argenx, Rigel and Bayer
Research funding from Sysmex, Novartis, Rigel, Principia, Argenx, Dova, Octapharma and Astra Zeneca

More from Michele Lambert

1:28
Differentiating immune thrombocytopenia from IPD and PID
Michele Lambert • 11 Oct 2021

Related Videos

1:13
The pitfalls in genomics for myeloid malignancies
Thomas Coats • 29 Apr 2024
3:12
Addressing cardiotoxicity following CAR-T therapy and improving clinical practice
Arjun Ghosh • 25 Apr 2024
4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals